Business
Creative Medical Technology Holdings To Present ImmCelz® Subsidiary At World Stem Cell Conference
PHOENIX, June 17, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC - CELZ), announced that the company will virtually present at the
About this update from Creative Medical Technology Holdings, Inc.
[{"type":"text","content":"PHOENIX, June 17, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC - CELZ), announced that the company will virtually present at the Investor Forum at the World Stem Cell Summit today Thursday, June 17, 2021 at 12:00pm Eastern Standard Time and will consist of a 20-minute formal description of the Company followed by a 20-minute Q&A session moderated by a Noble Capital Markets equity research representative.\n\n \n \n \n \n \n \n\n \nThe presentation can be accessed in two ways, by registering for the full World Stem Cell Summit www.worldstemcellsummit.com, or by registering (at no cost) for the Investor Forum only at www.channelchek.com. The video webcast will be later archived on Channelchek as part of its C-Suite Series www.channelchek.com/c-suite, and on its YouTube channel. www.youtube.com/channelchek.\n\"Presenting at The World Stem Cell Summit is an honor and we are grateful for the opportunity to showcase our ImmCelz® subsidiary.\" said Timothy Warbington, CEO of Creative Medical Technology Holdings Inc.\nAbout Creative Medical Technology Holdings Creative Medical Technology Holdings, Inc. (www.CreativeMedicalTechnology.com) is a commercial stage biotechnology company specializing in regenerative medicine/stem cell technology in the fields of immunotherapy (www.ImmCelz.com), urology (www.CaverStem.com and www.FemCelz.com) and orthopedics (www.StemSpine.com). \nAbout The World Stem Cell SummitProduced by the nonprofit Regenerative Medicine Foundation (RMF), the 2021 Summit is the most inclusive and expansive interdisciplinary networking and partnering meeting in the stem cell translation and regenerative medicine field. With the overarching purpose of fostering biomedical research, funding and investments targeting cures, the Summit is the single conference serving the diverse ecosystem of regenerative medicine stakeholders. Combined with the WFIRM & RMF Regenerative Medicine Essentials Course, the Summit provides distinctive educational and futuristic experiences through which all participants collect opportunities, become inspired and flourish.\nAbout Noble Capital Markets, Inc.Noble Capital Markets (\"Noble\") is a research driven boutique investment bank that has supported small & microcap companies since 1984. As a FINRA and SEC licensed broker dealer Noble provides institutional-quality equity re...
More updates from Creative Medical Technology Holdings, Inc.